Table 5.
GR50 value of HLJ and SD22 populations treated with nicosulfuron in the presence or absence of cytochrome P450 (CYP450) and glutathione S-transferase (GST) inhibitors.
| Treatments | Type of inhibitor | HLJ | SD22 | RI | ||
|---|---|---|---|---|---|---|
| GR50 ± SE | GR50 Reduction(%) | GR50 ± SE | GR50 Reduction(%) | |||
| Nicosulfuron | – | 74.20 ± 4.88 | – | 30.23 ± 0.52 | – | 2.45 |
| Nicosulfuron + Malathion | CYP450 | 37.10 ± 4.60 | 50.00 | 13.74 ± 0.04 | 54.55 | 2.70 |
| Nicosulfuron+PBO | CYP450 | 7.26 ± 0.31 | 90.22 | 7.47 ± 0.96 | 75.29 | 0.97 |
| Nicosulfuron+NBD-Cl | GST | 51.18 ± 6.02 | 31.02 | 10.04 ± 0.34 | 66.79 | 5.09 |
The symbol "-" represents a null value.